$10.64▴ 2.11%
End-of-day close · 2026-08-06
What most investors miss
Trends, drivers and alerts — the full picture.
Profit → Cash
Not enough data yet
Valuation
Not enough data yet
Not enough valuation history to place this in context.
Revenue growth
Not enough data yet
Not enough revenue history to measure growth.
Leverage
Not enough data yet
More coming: dilution / share-count creep.
✦ The read
Telix Pharmaceuticals Limited - American Depositary Shares's earnings-quality signal is not available yet.
Key numbers
Recent news
Sentiment · last 30 days15 articles
8 bullish7 neutral0 bearish
Worried About the Market? These Stocks Have a Track Record of Helping Investors Sleep at Night.Telix H1 2026 Results: Investor Webcast Notification
Johnson & Johnson vs. Eli Lilly: Reliable Stability vs. Rapid Revenue GrowthGlobal Pharmaceutical Surfactants Market Size/Share Worth USD 6.93 Billion by 2035 at a 4.42% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)
Which ETF Is Healthier for Your Portfolio: Vanguard Health Care ETF or iShares Pharmaceuticals ETF?